22.418 articles found

Transdermal therapeutic system for Parkinson's Disease

WOLFF HANS-MICHAEL.

· 2005-09-29

NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF.

ZOU NING.

· 2005-09-29

NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

SEKIGUCHI YOSHINORI, KANUMA KOSUKE, OMODERA KATSUNORI, BUSUJIMA TSUYOSHI, TRAN THUY ANH, HAN SANG DON, CASPER MARTIN, KRAMER BRYAN A, SEMPLE GRAEME, ZOU NING.

· 2005-09-29

KASPP (LRRKE) GENE, ITS PRODUCTION AND USE FOR THE DETECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

MEITINGER Thomas, STROM Tim Matthias, BISKUP Saskia, UEFFING Marius, KREMMER Elisabeth, GLOECKNER Christian J., GASSER Thomas, LEITNER Petra, ASMUS Friedrich, PATENGE Nadja, ZIMPRICH Alexander, FARRER Matthew J., KACHERGUS Jennifer M., LINCOLN Sara J., HULIHAN Mary M., WSZOLEK Zibigniew, UITTI Ryan.

· 2005-09-27

KASPP (LRRK2) GENE, ITS PRODUCTION AND USE FOR THE DETECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

MEITINGER Thomas, STROM Tim Matthias, BISKUP Saskia, UEFFING Marius, KREMMER Elisabeth, GLOECKNER Christian J., GASSER Thomas, LEITNER Petra, ASMUS Friedrich, PATENGE Nadja, ZIMPRICH Alexander, FARRER Matthew J., KACHERGUS Jennifer M., LINCOLN Sara J., HULIHAN Mary M., WSZOLEK Zibigniew, UITTI Ryan.

· 2005-09-27

Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders

MEITINGER THOMAS, STROM TIM MATTHIAS, BISKUP SASKIA, UEFFING MARIUS, KREMMER ELISABETH, GLOECKNER CHRISTIAN, GASSER THOMAS, LEITNER PETRA, ASMUS FRIEDRICH, PATENGE NADJA, ZIMPRICH ALEXANDER, FARRER MATTHEW J, KACHERGUS JENNIFER M, LINCOLN SARA J, HULIHAN MARY M, WSZOLEK ZIBIGNIEW, UITTI RYAN.

· 2005-09-27

KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative disorders

GASSER THOMAS PROF DR.

· 2005-09-27

Human embryonic germ cells for future neuronal replacement therapy.

Turnpenny L, Cameron IT, Spalluto CM, Hanley KP, Wilson DI, Hanley NA.

Brain Res Bull · 2005-09-15

DOI: 10.1016/j.brainresbull.2005.08.014PMID: 16325007

Movement disorders secondary to long-term treatment with cyclosporine A.

Munhoz RP, Teive HA, Germiniani FM, Gerytch JC, Sá DS, Bittencourt MA, Pasquini R, Camargo CH, Werneck LC.

Arq Neuropsiquiatr · 2005-09-09

DOI: 10.1590/s0004-282x2005000400007PMID: 16172706

Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.

da Silva-Júnior FP, Braga-Neto P, Sueli Monte F, de Bruin VM.

Parkinsonism Relat Disord · 2005-09-09

DOI: 10.1016/j.parkreldis.2005.05.008PMID: 16154788

The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease.

Schillaci O, Pierantozzi M, Filippi L, Manni C, Brusa L, Danieli R, Bernardi G, Simonetti G, Stanzione P.

Eur J Nucl Med Mol Imaging · 2005-09-08

DOI: 10.1007/s00259-005-1922-9PMID: 16151764

METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR THE TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

SCHAFER PETER H.

· 2005-09-06